Stocktoria
Apogee Therapeutics, Inc. APGE
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-07-14
Apogee Therapeutics, Inc. statistics & valuation
Market cap$10.0B
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -27.3% | -24.2% | -20.9% | -26.2% |
| Current ratio | 26.57 | 18.55 | 19.38 | 15.24 |
Source: SEC EDGAR filings · CIK 0001974640 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.